51 / 88
51
Wednesday, 21 June 2017
/ Scientific Programme
WFSBP 2017
WED
T11: DEPRESSION: BASIC/ CLINICAL
S-47
SYMPOSIUM
08:30–10:00
B3 M1-M2
Catecolamines, anhedonia and depression
Chair:
Jose Luis Ayuso Gutierrez, Spain
Co-Chair: Victoria Valdez, Ecuador
001
Catecholamines, reward circuits and depression
Gregor Hasler, Switzerland
002
Positive affects and depression
Jorge Tellez-Vargas, Colombia
003
Anhedonia and suicide behavior
Maurizio Pompili, Italy
004
Exploring the role of proinflammatory cytokines
in anhedonia
Ruby Castilla-Puentes, USA
FC-09
FREE COMMUNICATION SESSION
08:30–10:00
Auditorium 12
Depression 1
Chair:
Lars Vedel Kessing, Denmark
Co-Chair: Vibe G. Frokjaer, Denmark
001
Blood biomarkers to predict suicidal behavior
Bérengère Vire, France
D. Weissmann, N. Salvetat, S. Pointet, Y. Lannay,
G. Marcellin, S. van der Laan, F. Molina, P. Courtet,
P. A. Saiz
002
Transcranial direct current stimulation for treat-
ment-resistant depression: An open-label study for
8 weeks
Galen Hung, Taiwan
M.-S. Li
003
Season-independent cognitive deficits in seasonal af-
fective disorder and their relation to depressive symptoms
Liv Vadskjær Hjordt, Denmark
D. S. Stenbæk, B. Ozenne, B. Mc Mahon, I. Hageman,
S. G. Hasselbalch, G. M. Knudsen
004
Functional network-based statistics in depression:
theory of mind subnetwork and importance of parietal
region
Chien-Han Lai, Taiwan
Y.-T. Wu
005
Gene expression profiles within a pharmacologi-
cally induced depression model: The role of estrogen in
perinatal depression
Vibe G. Frokjaer, Denmark
D. Mehta, M. Rex-Haffner, A. Pinborg, E. Binder,
V. G. Frokjaer
FC-10
FREE COMMUNICATION SESSION
08:30–10:00
B3 M3-M4
Antipsychotics 2
Chair:
Kohji Fukunaga, Japan
002
Importance of early changes of blood lipid levels
to predict long-term dyslipidemia during psychotropic
drug treatment
Aurélie Delacrétaz, Switzerland
F. Vandenberghe, N. Saigi-Morgui, A. Glatard,
M. Gholam-Rezaee, A. von Gunten, P. Conus, C. Eap
003
Association of body mass index with socioeconomic
factors in Swiss psychiatric cohorts
Axel Levier, Switzerland
N. Saigi-Morgui, A. Delacrétaz, F. Vandenberghe,
A. Glatard, M. Gholam-Rezaee, R. Panczak,
A. von Gunten, P. Conus, C. Eap
004
Discovery of a novel intracellular dopamine D2
receptor function
Kohji Fukunaga, Japan
N. Shioda
005
Altered cerebral concentration of major inhibitory
neurotransmitter in the medicated UHR subjects: 1H
MRS study
Petr Menshchikov, Russia
N. Semenova, T. Akhadov
PL-03
PLENARY SESSION
10:15–11:00
Auditorium 15
Epigenetic consequences of early adversity:
Implications for psychiatric disorders
Chair:
Constantin Soldatos, Greece
Speaker: Elisabeth Binder, Germany
D-03
DEBATE
11:15–12:45
Auditorium 15
Deep brain stimulation is a worthwhile treatment
method in psychiatry
Chair:
Gregers Wegener, Denmark
Proponent: Thomas Schläpfer, Germany
Opponent: Marwan Hariz, United Kingdom